3/5
01:50 pm
eras
Tango rises after Q4 results, clinical pact with Erasca [Seeking Alpha]
Low
Report
Tango rises after Q4 results, clinical pact with Erasca [Seeking Alpha]
3/5
07:41 am
eras
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
Low
Report
Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights [Yahoo! Finance]
3/5
07:13 am
eras
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat [Yahoo! Finance]
Low
Report
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat [Yahoo! Finance]
3/5
07:01 am
eras
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
Low
Report
Erasca and Tango Therapeutics Enter into Clinical Collaboration to Evaluate Combination of ERAS-0015 and Vopimetostat
3/2
04:22 pm
eras
Assessing Erasca (ERAS) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing Erasca (ERAS) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
2/28
07:02 pm
eras
Erasca Conference: ERAS Teases 2026 Catalysts for Pan-RAS ERAS-0015 and Pan-KRAS ERAS-4001 [Yahoo! Finance]
Medium
Report
Erasca Conference: ERAS Teases 2026 Catalysts for Pan-RAS ERAS-0015 and Pan-KRAS ERAS-4001 [Yahoo! Finance]
2/28
03:22 pm
eras
Erasca, Inc. (ERAS): A Bull Case Theory [Yahoo! Finance]
Medium
Report
Erasca, Inc. (ERAS): A Bull Case Theory [Yahoo! Finance]
2/24
08:00 am
eras
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
Medium
Report
Erasca Announces Issuance of a U.S. Patent Covering Pan-KRAS Inhibitor ERAS-4001
11/12/2025
04:01 pm
eras
erasca, inc.
IN-LINE
Report
-5.1%
erasca, inc.
8/12/2025
04:01 pm
eras
erasca, inc.
IN-LINE
Report
3.8%
erasca, inc.
5/13/2025
04:05 pm
eras
erasca, inc.
BEAT
Report
-4.5%
erasca, inc.
3/4
05:39 pm
eras
Form 144 Erasca, Inc. Filed by: Morris Shannon
Low
Report
Form 144 Erasca, Inc. Filed by: Morris Shannon
2/17
02:27 pm
eras
Form 144 Erasca, Inc. Filed by: Erasca Foundation
Low
Report
Form 144 Erasca, Inc. Filed by: Erasca Foundation
2/17
10:28 am
eras
Form SCHEDULE 13G/A Erasca, Inc. Filed by: T. Rowe Price Investment Management, Inc.
Medium
Report
Form SCHEDULE 13G/A Erasca, Inc. Filed by: T. Rowe Price Investment Management, Inc.
1/30
09:05 am
eras
Form 4 Erasca, Inc. For: Jan 29 Filed by: Lim Jonathan E
Medium
Report
Form 4 Erasca, Inc. For: Jan 29 Filed by: Lim Jonathan E
1/30
09:04 am
eras
Form 4 Erasca, Inc. For: Dec 15 Filed by: Chacko David M.
Medium
Report
Form 4 Erasca, Inc. For: Dec 15 Filed by: Chacko David M.
1/30
09:02 am
eras
Form 4 Erasca, Inc. For: Jan 29 Filed by: Morris Shannon
Medium
Report
Form 4 Erasca, Inc. For: Jan 29 Filed by: Morris Shannon
1/30
09:01 am
eras
Form 4 Erasca, Inc. For: Jan 29 Filed by: Varney Michael David
Medium
Report
Form 4 Erasca, Inc. For: Jan 29 Filed by: Varney Michael David
1/30
09:00 am
eras
Form 4 Erasca, Inc. For: Jan 29 Filed by: Garner Ebun
Medium
Report
Form 4 Erasca, Inc. For: Jan 29 Filed by: Garner Ebun
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register